These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8631656)

  • 1. Gene replacement strategies for cancer.
    Roth JA
    Isr J Med Sci; 1996 Feb; 32(2):89-94. PubMed ID: 8631656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Replacement Strategies for Lung Cancer.
    Roth JA; Mukhopadhyay T; Zhang WW; Fujiwara T; Georges R
    Semin Radiat Oncol; 1996 Apr; 6(2):105-109. PubMed ID: 10717169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
    Zhang WW; Roth JA
    In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 tumor suppressor gene therapy for cancer.
    Nielsen LL; Maneval DC
    Cancer Gene Ther; 1998; 5(1):52-63. PubMed ID: 9476967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy of malignant tumors].
    Hauses M; Schackert HK
    Zentralbl Chir; 2000; 125 Suppl 1():41-6. PubMed ID: 10929646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for cancer gene therapy.
    Hughes RM
    J Surg Oncol; 2004 Jan; 85(1):28-35. PubMed ID: 14696084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human gene therapy for lung cancer].
    Fujiwara T; Inoue F; Tanaka N
    Nihon Rinsho; 1997 May; 55(5):1296-306. PubMed ID: 9155189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular therapy in malignant tumors].
    Fey MF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1758-63. PubMed ID: 10603649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
    Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
    Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
    Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral and non-viral vectors for cancer gene therapy.
    Cristiano RJ
    Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of tumour suppressor gene expression for cancer.
    Roth JA
    Forum (Genova); 1998; 8(4):368-76. PubMed ID: 9863031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for pancreatic cancer.
    Kasuya H; Nomoto S; Kimata H; Harada A; Takeda S; Hayashi S; Nakao A
    Hepatogastroenterology; 2001; 48(40):957-61. PubMed ID: 11490848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.
    Odin L; Favrot M; Poujol D; Michot JP; Moingeon P; Tartaglia J; Puisieux I
    Cancer Gene Ther; 2001 Feb; 8(2):87-98. PubMed ID: 11263530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of lung cancer.
    Daniel JC; Smythe WR
    Semin Surg Oncol; 2003; 21(3):196-204. PubMed ID: 14508853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.